4.7 Review

The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer

Journal

BIOMOLECULES
Volume 11, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/biom11040531

Keywords

insulin-like growth factor-1 (IGF1); IGF1 receptor; insulin receptor; transcription factors; cancer; cell nucleus

Funding

  1. Israel Science Foundation
  2. US-Israel Binational Science Foundation
  3. Israel Cancer Association
  4. Recanati Foundation

Ask authors/readers for more resources

InsR and IGF1R exhibit transcription factor-like activities in the cell nucleus, including specific DNA binding and transcriptional control. Nuclear IGF1R is capable of binding and stimulating its cognate gene promoter, but the physiological relevance of this autoregulatory mechanism requires further investigation. In addition to nuclear localization, IGF1R has been identified in the Golgi apparatus, which correlates with a migratory phenotype.
Insulin (InsR) and insulin-like growth factor-1 (IGF1R) receptors mediate the metabolic and growth-promoting actions of insulin and IGF1/IGF2, respectively. Evidence accumulated in recent years indicates that, in addition to their typical cell-surface localization pattern and ligand-activated mechanism of action, InsR and IGF1R are present in the cell nucleus of both normal and transformed cells. Nuclear translocation seems to involve interaction with a small, ubiquitin-like modifier protein (SUMO-1), although this modification is not always a prerequisite. Nuclear InsR and IGF1R exhibit a number of biological activities that classically fit within the definition of transcription factors. These nuclear activities include, among others, sequence-specific DNA binding and transcriptional control. Of particular interest, nuclear IGF1R was capable of binding and stimulating its cognate gene promoter. The physiological relevance of this autoregulatory mechanism needs to be further investigated. In addition to its nuclear localization, studies have identified IGF1R in the Golgi apparatus, and this particular distribution correlated with a migratory phenotype. In summary, the newly described roles of InsR and IGF1R as gene regulators, in concert with their atypical pattern of subcellular distribution, add a further layer of complexity to traditional models of cell signaling. Furthermore, and in view of the emerging role of IGF1R as a potential therapeutic target, a better understanding of the mechanisms responsible for nuclear IGF1R transport and identification of IGF1R interactors might help optimize target directed therapies in oncology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cell Biology

Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways

Haim Werner, Lena Lapkina-Gendler, Laris Achlaug, Karthik Nagaraj, Lina Somri, Danielle Yaron-Saminsky, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Shoshana Yakar

CELLS (2019)

Article Cell Biology

Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells

Rive Sarfstein, Karthik Nagaraj, Derek LeRoith, Haim Werner

CELLS (2019)

Review Cell Biology

Effects of GH/IGF on the Aging Mitochondria

Sher Bahadur Poudel, Manisha Dixit, Maria Neginskaya, Karthik Nagaraj, Evgeny Pavlov, Haim Werner, Shoshana Yakar

CELLS (2020)

Editorial Material Cell Biology

Insulin-Like Growth Factors in Development, Cancers and Aging

Haim Werner

CELLS (2020)

Article Cell Biology

The Olfactory Receptor Gene Product, OR5H2, Modulates Endometrial Cancer Cells Proliferation via Interaction with the IGF1 Signaling Pathway

Rand Shibel, Rive Sarfstein, Karthik Nagaraj, Lena Lapkina-Gendler, Zvi Laron, Manisha Dixit, Shoshana Yakar, Haim Werner

Summary: Endometrial cancer is commonly linked to the insulin-like growth factor-1 (IGF1) axis, while individuals with Laron syndrome (LS) are protected from cancer development due to IGF1 deficiency. The downregulation of OR5H2 gene in LS-derived cells suggests a potential role in endometrial cancer as a target for positive regulation by IGF1.

CELLS (2021)

Article Biochemistry & Molecular Biology

MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression

Danielle Yaron-Saminsky, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik-Chor, Haim Werner

Summary: The GH-IGF1 hormonal system is important in growth, metabolism, and disease development. LS, caused by a mutation in the GH receptor gene, may be associated with reduced cancer risk due to differential miR expression levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Identification of UDP-Glucuronosyltransferase 2B15 (UGT2B15) as a Target for IGF1 and Insulin Action

Rive Sarfstein, Karthik Nagaraj, Shivang Parikh, Carmit Levy, Zvi Laron, Dafna Benayahu, Haim Werner

Summary: Normal growth and development are controlled by genetic and metabolic factors, with the GH-IGF1 hormonal axis playing a key role. LS patients have reduced cancer risk, and the UGT2B15 gene may be a novel target for IGF1 action.

CELLS (2022)

Article Cell Biology

Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP

Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Haim Werner

Summary: The GH/IGF1 pathway plays a crucial role in cellular interactions, metabolism, growth, and aging. Patients with LS have a reduced risk of developing cancer, and the discovery of IGF1 and TXNIP provides new insights into cellular redox regulation. The IGF1-TXNIP axis is essential for maintaining cellular homeostasis.

CELLS (2022)

Review Cell Biology

Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation

Haim Werner, Rive Sarfstein, Karthik Nagaraj, Zvi Laron

CELLS (2020)

No Data Available